Company / AR per Share
Amneal Pharmaceuticals, Inc. AR per Share History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$4.98
FY2022
5-year range
$4.98 / $5.02
FY2018-FY2022
Trend
-0.7%
vs FY2021
Sector context
#20 of 113
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s ar per share of $4.98 is higher than 82% of companies in the Health Care sector (FY2022).
Based on SEC 10-K filings.
4.98 in FY2022 with a 5-year CAGR of -89.3%. Top quartile in the Health Care sector.
Remained stable around $4.98 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- -89.3%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 113This company $4.98 Sector average $28.83
▼
-82.7% below sector average
Key checks
Key Insights
- In FY2022, ar per share decreased 0.7% year-over-year.
- Ranks #20 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2017.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $4.98 | -0.7% |
| FY2021 | $5.02 | -0.1% |
| FY2020 | $5.02 | +5.7% |
| FY2019 | $4.75 | +25.5% |
| FY2018 | $3.78 | -100.0% |
| FY2017 | $351367.00 | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026